Yonhap KoreanKO
삼성증권 "대웅제약, 펙스클루 국내 매출 급감"…목표가↓
(서울=연합뉴스) 김태종 기자 = 삼성증권은 5일 대웅제약[069620]에 대해 투자의견을 '매수'로 유지하면서도 목표주가는 18만원에서 15만...
🇰🇷 대한민국 / 한국어
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.